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Abstract
Multi-marker tests hold promise for identifying symptomatic women at risk of imminent pre-
term delivery (PTD, 37 week’s gestation). This study sought to determine the relationship
of inflammatory mediators and metabolites in cervicovaginal fluid (CVF) with spontaneous
PTD (sPTD) and delivery within 14 days of presentation with symptoms of preterm labour
(PTL). CVF samples from 94 (preterm = 19, term = 75) singleton women with symptoms of
PTL studied between 19+0–36+6 weeks’ gestation were analysed for cytokines/chemokines
by multiplexed bead-based immunoassay, while metabolites were quantified by enzyme-
based spectrophotometry in a subset of 61 women (preterm = 16, term = 45). Prevalence of
targeted vaginal bacterial species was determined for 70 women (preterm = 14, term = 66)
by PCR. Overall, 10 women delivered within 14 days of sampling. Predictive capacities of
individual biomarkers and cytokine-metabolite combinations for sPTD and delivery within 14
days of sampling were analysed by logistic regression models and area under the receiver
operating characteristic curve. Fusobacterium sp., Mubiluncus mulieris and Mycoplasma
hominis were detected in more preterm-delivered than term women (P0.0001), while, M.
curtisii was found in more term-delivered than preterm women (P0.0001). RANTES (0.91,
0.65–1.0), IL-6 (0.79, 0.67–0.88), and Acetate/Glutamate ratio (0.74, 0.61–0.85) were asso-
ciated with delivery within 14 days of sampling (AUC, 95% CI). There were significant corre-
lations between cytokines and metabolites, and several cytokine-metabolite combinations
were associated with sPTD or delivery within 14 days of sampling (e.g. L/D-lactate ratio
+Acetate/Glutamate ratio+IL-6: 0.84, 0.67–0.94). Symptomatic women destined to deliver
preterm and within 14 days of sampling express significantly higher pro-inflammatory medi-
ators at mid to late gestation. In this cohort, IL-6, Acetate/Glutamate ratio and RANTES
were associated with delivery within 14 days of sampling, consistent with their roles in modu-
lating infection-inflammation-associated preterm labour in women presenting with symp-
toms of preterm birth. Replication of these observations in larger cohorts of women could
show potential clinical utility.
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Introduction
Preterm delivery (PTD, before 37 weeks of gestation) remains the dominant global cause of
perinatal morbidity and mortality. Preterm labour (PTL) is suspected when a woman presents
with frequent uterine contractions occurring at least once every 5–8 minutes, cervical dilation
>2 cm and cervical effacement (�50%) before 37 weeks’ gestation [1]. Approximately 45% of
PTDs are preceded by spontaneous PTL, while ~30% follow preterm premature rupture of
membranes (PPROM) [2]. Majority of women presenting with symptoms of PTL do not even-
tually deliver preterm and would benefit from better prognostication of those most likely to
imminently deliver preterm [3]. Accurate identification of these pregnant women facilitates
prompt clinical decision-making, maternal treatment with steroids to aid fetal lung matura-
tion, minimises unnecessary hospitalisations, and improves triaging of patients to centres with
optimal neonatal care facilities.
The most commonly employed clinical test for predicting imminent PTD are quantitative
fetal fibronectin (qfFN) and insulin-like growth factor binding protein-1 (Actim Partus) [4–7],
however, due to the heterogeneity of the pathophysiology of PTD, several studies have
explored other maternal clinical, inflammation and biochemical markers to predict PTD
within 7–14 days in women presenting with symptoms of PTL [3, 8]. Previously we showed
that decreased cervicovaginal fluid (CVF) acetate, probably produced by vaginal mixed anaer-
obes in the absence of Lactobacillus dominance, appears a suitable “rule-out” marker for deliv-
ery within 2 weeks in symptomatic women [9, 10]. Low CVF glutamate is also associated with
reduced vaginal fluid acidity and bacterial vaginosis (BV) [11], an established risk factor of
PTD [12–14]. We have also recently demonstrated the predictive value of several CVF pro-
inflammatory mediators, either singly or in combination with qfFN for spontaneous PTD
(sPTD) in high risk women without symptoms of PTL [15]. Combining multiple potential
markers implicated in the pathogenesis of sPTD may provide a more accurate clinical screen-
ing approach [7, 16, 17].
Therefore, to determine whether CVF metabolites and cytokines/chemokines assessment
enhanced the prediction of sPTD and delivery within 14 days of presentation with symptoms
suggestive of PTL, we investigated the relationship between these markers of infection/inflam-
matory and sPTD and delivery within 14 days of presentation. We hypothesised that symp-
tomatic pregnant women who eventually deliver prematurely, within 14 days of presentation/
sampling, will show higher CVF pro-inflammatory mediators and acetate/glutamate ratio
compared to those that delivered afterwards. Furthermore, a multivariable approach may pro-
vide a more comprehensive analysis of the patho-mechanism of sPTD.
Methods
In this study, CVF samples were obtained from 94 women presenting with symptoms of PTL
(19+0–36+6 weeks’ gestation) at the Labour Ward Assessment Suite of the Jessop Wing Mater-
nity Hospital, Sheffield, UK,—regular uterine contractions (at least once every 10 mins) and
cervical dilatation<3 cm, intact fetal membranes and no clinical evidence of genitourinary
tract infection, abnormal cervical cytology or vaginal bleeding. CVF samples were obtained
prior to any vaginal examination or clinical intervention such as administration of antibiotics,
tocolytics, steroids, or any vaginal pessary.
Study participants were enrolled between January 2014 and March 2017 and closely moni-
tored until delivery outcomes were ascertained. Immediately after the swab samples were
obtained, quantitative fetal fibronectin (qfFN), vaginal sonographic determination of cervical
length (CL) as well as vaginal pH measurement were also performed as previously reported [9,
10, 18, 19].
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These studies were approved by the Yorkshire and Humber (Sheffield) Committee of the
UK National Research Ethics Service (REC Number 13/YH/0167).
CVF sample collection and preparation
Through a sterile Cusco’s vaginal speculum, 2 high vaginal swabs were obtained from the pos-
terior vaginal fornix of each pregnant woman with sterile Dacron swab (Deltalab Eurotubo
300263, Fisher Scientific, UK) at presentation. The swabs were processed as previously
described [9, 10, 18, 19]. Briefly, immediately after collection, swabs were stored at -20˚C and
processed within 1–3 days. The swabs were processed by placing in a 1.5 μl microfuge tube
containing 400 μl (bacterial DNA extraction) and 600 μl (metabolite analysis) isotonic Phos-
phate Buffered Saline (PBS). The microfuge tube containing the cut end of the swab in PBS
was vortexed for 5 minutes to wash the CVF into solution. The swab tip was safely discarded,
and the remaining solution was centrifuged for 3 minutes at 13,000 rpm after which the super-
natant was aspirated into a fresh tube and preserved at -80˚C until further analysis.
CVF cytokine measurement
From the 400 μl CVF sample reserved for bacterial DNA extraction, 50 μl was aspirated and
transferred into a new 1.5 μl microfuge tube and analysed for IL-1ċ, IL-1Č, IL-2, IL-4, IL-6, IL-
8, IL-10, IL-12p20, RANTES, TNF-r1, and IFN-č by multiplexed bead-based immunoassay
(BDTM Cytometric Bead Array, BD Biosciences, CA, USA). This was performed according to
the BD CBA Human Soluble Protein Master Buffer Kit instruction (See text in S1 File). Briefly,
standard solutions of each cytokine (for calibration curve), and 25 μl CVF samples were mixed
with a 25 μl solution of capture beads-antibodies conjugate (left for 1 hour) and then 25 μl Phy-
coerythrin detection reagent (left for additional 2 hours) at room temperature. The samples
were then washed, centrifuged individually, left for resuspension, and then transferred to the
plate. Mean Fluorescence Intensity (MFI) were generated by a Life Technologies Attune
Acoustic Focusing Cytometry and Attune NxT Cytometric Software v.2.1. Actual cytokine
concentrations in each sample was extrapolated from the generated standard curve. Cytokine
analyses were performed by staff blinded from patient’s clinical data and eventual delivery
outcome.
1H-NMR Spectroscopy
From the CVF samples dissolved in 600 μl PBS, 400 μl containing 20 μl D2O was analysed by
1H-Nuclear Magnetic Resonance (NMR) spectroscopy using a 400 MHz (9.4T) Bruker Avance
III NMR spectrometer (Bruker BioSpin GmbH, Karlsruhe, DE), with 5mm BBO probe. Lac-
tate, acetate, glutamate and other metabolites implicated in vaginal host-microbial activities,
infection and PTD were identified in the 1H-NMR spectrum (S1 Fig). Further analyses, inte-
gration and normalisation to obtain normalised integrals (n.i.) of identified metabolites were
also performed as described previously [9, 10, 18, 19].
CVFmetabolite measurement by spectrophotometry
The NMR-guided metabolites were chosen as the basis for a cheaper clinically applicable test
[20]. We measured absolute concentrations of metabolites by enzyme-based spectrophotomet-
ric assays (Megazyme, IE): acetate (K-ACETGK 08/14), glutamate (K-GLUT 07/12), L- and D-
lactate (K-LATE 07/14 and K-DATE 04/14), glucose (K-GLUHK-110A/K-GLUHK-220A 07/
14), pyruvate (K-PYRUV 04/14), urea (K-URAMR 07/17), and succinate (K-SUCC 01/14),
from a randomly selected subgroup of 61 women (preterm = 16, term = 45, i.e. all women
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whose delivery outcomes where known at the time of analysis).). All measurements except
pyruvate and urea were performed on the ChemWell1 2910 auto-analyser (Awareness Tech-
nology, USA). Measurement of urea was performed on the ChemWell1-T auto-analyser
(Awareness Technology, USA), while pyruvate measurement was on the MegaQuant wave
spectrophotometer (Megazyme, IE).
Polymerase chain reaction (PCR)
To identify the potential microbial composition/stimulus inducing the expression of metabo-
lites and cytokines, the prevalence of targeted vaginal bacterial species was also determined for
a random subgroup of 70 women (preterm = 14, term = 66) by PCR (i.e. all women whose
delivery outcomes where known at the time of analysis). Bacterial 16S rDNA were extracted
using the QIAamp DNAmini kit (Qiagen, UK) and amplified by genus/species-specific prim-
ers (Sigma-Aldrich, UK, S1 Table) [21–24], as previously described [15, 18]. Amplification was
performed on an Applied Biosystems 2720 Thermal cycler (Life Technologies, UK) using a
25 μl reaction mix containing 12.5 μl AmpliTaq Gold DNA polymerase (Applied Biosystems,
UK), 5 ng genomic DNA template, 1 μl each of 10 μM forward and reverse primers. The
cycling criteria included 95˚C (5 mins)–denaturation, followed by 35 cycles of 95˚C (1 min)—
denaturing, 50–62˚C depending on the primer sets (1 min)–annealing, 72˚C (1 min)–elonga-
tion, with a final extension at 72˚C (7 mins). The amplicons were visualized/confirmed on a
UV- transilluminator by 1% agarose gel electrophoresis stained with ethidium bromide. Posi-
tive results were assigned according to the presence of bands of appropriate size relative to the
DNAmarker. Bacterial 16S rDNA standards were also used as positive controls.
Statistical analysis
Data were subjected to Shapiro-Wilk normality tests prior to analyses. Differences in maternal
clinical data, CVF cytokine and metabolite concentrations between term- and preterm-deliv-
ered women as well as between women that delivered within and after 2 weeks of sampling
were determined by Mann-Whitney U test. The relationships between cytokine, metabolite
expression levels and maternal clinical and demographic variables were determined by non-
parametric Spearman’s (rho) correlation coefficients. P-values< 0.05 were considered statisti-
cally significant. Bonferroni corrections were applied for multiple measurements and
correlations. The differences in the prevalence of vaginal bacterial species between preterm-
and term-delivered women were determined by Fisher’s exact test. Predictive capacities of
CVF cytokine-metabolite combinations for sPTD (< 37 weeks of gestation) and delivery
within 2 weeks of sampling were analysed by logistic regression models and area under the
receiver operating characteristic curve (AUC). All analyses were performed using SPSS 24
(SPSS Inc., IL, USA), GraphPad Prism 7.03 (GraphPad Software, Inc. USA), and MedCalc 18.9
(MedCalc Software bvba, Ostend, BE; http://www.medcalc.org; 2018) statistical software
packages.
Results
Maternal demographic and clinical details
Ninety-four women (preterm = 19, term = 75) with singleton pregnancies presenting with
symptoms of PTL were enrolled in the study. Nineteen (20.2%) women delivered preterm, of
which 10 (10.6%) delivered within 2 weeks of sampling. All women included in this study
experienced spontaneous onset of labour, while those that underwent elective caesarean sec-
tion without prior labour were excluded. Details of maternal demographic and clinical data
Predicting preterm delivery within 2 weeks of presentation
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are presented in Table 1. The preterm-delivered women had significantly higher BMI
(P = 0.02) and qfFN (P = 0.005) and shorter CL (P = 0.002) compared to the term-delivered
women. Most of the demographic and clinical characteristics were similar in women who
delivered within and after 2 weeks of sampling, except that the women who delivered within 2
weeks of sampling were older (P = 0.03) than those that delivered later.
Prevalence of vaginal anaerobic bacterial species
The individual prevalence of Fusobacterium sp. (21%),Mubiluncus mulieris (18.4%) andMyco-
plasma hominis (19.5%) was found to be higher in the preterm women compared to their term
counterparts (P< 0.0001), while,M. curtisii was found in 11.6% more term-delivered than
preterm women (P< 0.0001) (Fig 1). Furthermore, Fusobacterium sp. andM. hominis were
more prevalent in women who delivered within 2 weeks of sampling, whereasM. curtisii and
M.mulieris were more prevalent in women that delivered later than 2 weeks of sampling
(P< 0.0001) (Fig 1). The prevalence of Gardnerella vaginalis, Bacteroides sp., and Lactobacillus
sp., which were present in at least 77%, 48% and 98% of the women respectively regardless of
the sub-grouping, did not differ significantly between the groups. Group B Streptococcus was
only identified in one woman who delivered at term.
CVF cytokine concentrations
CVF cytokine concentrations in relation to delivery outcomes are presented in Table 2. TNF-
r1 (P = 0.006), RANTES (P = 0.02), IL-6 (P = 0.03) were significantly higher in preterm-deliv-
ered women compared to the term women. Additionally, RANTES (P = 0.02) and IL-6
(P = 0.03) were significantly higher in women who delivered within 2 weeks of sampling com-
pared to those who delivered afterward. None of the other cytokines i.e. IL-1ċ and Č, and IL-8
showed significant differences in relation to delivery outcomes between the cohorts, while IL-
2, IL-4, IL-10, IL-12p70 and IFN-č were below the detectable limit of the assay kit in all the
samples and were omitted in subsequent analyses.
Metabolite concentration measured by spectrophotometry
We have previously shown good correlation between 1H-NMR and biochemical assay [10].
Table 3 shows differences in metabolite concentrations measured by spectrophotometry
between study cohorts. Similar to 1H-NMR-derived normalised integrals, the absolute concen-
tration of acetate was higher in the women who delivered within 2 weeks of sampling
Table 1. Maternal clinical and demographic details according to delivery outcomes.
Characteristic Term (N = 75) Preterm (N = 19) P-value >2 weeks (N = 84) <2 weeks (N = 10) P-value
Age, years 26.8±5.7 (n = 70) 29.9±8.1 (n = 17) 0.2 26.9±5.8 (n = 74) 32.7±8.4 (n = 9) 0.03
BMI, kg/m2 25.4±5.0 (n = 60) 28.6±5.7 (n = 14) 0.02 25.8±5.4 (n = 65) 26.2±3.6 (n = 7) 0.4
GAAP, weeks 30±3.8 (n = 75) 28.8±3.2 (n = 19) 0.2 29.8±3.9 (n = 80) 29.5±2.8 (n = 10) 0.6
GAAD, weeks 39.0±1.2 (n = 71) 31.6±3.1 (n = 19) <0.0001 38.3±2.3 (n = 80) 30.2±2.9 (n = 10) <0.0001
qfFN, ng/ml 19.2±31.6 (n = 45) 215.5±227.8 (n = 10) 0.005 44.0±105.0 (n = 47) 187.6±233.1 (n = 5) 0.1
CL, mm 30.9±10.1 (n = 42) 18.4±13.4 (n = 12) 0.002 28.7±10.8 (n = 45) 18.7±17.4 (n = 6) 0.1
Vaginal pH 4.2±0.6 (n = 41) 4.3±0.8 (n = 11) 0.9 4.2±0.6 (n = 43) 4.6±0.9 (n = 6) 0.3
Data are presented as Median ± standard deviation (SD). Nine of the preterm women delivered after 2 weeks of sampling. BMI, body mass index; qfFN, quantitative fetal
fibronectin; CL, cervical length; GAAP, gestational age at presentation; GAAD, gestational age at delivery. n = reduced study population where participants’ consent and/
or data are absent.
https://doi.org/10.1371/journal.pone.0222455.t001
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compared to those that delivered later (P = 0.047), as reported previously in a smaller popula-
tion [10]. Although the glutamate concentration was not significantly different, the ratio (Ace/
Glxconc.) was more than 4-fold higher in the women who delivered within 2 weeks (P = 0.03)
and was associated with delivery within 2 weeks of presentation with PTL (AUC = 0.74)
(Table 3 and Fig 2). Predictive utility of spectrophotometry by ROC analysis was similar to the
1H-NMR-derived ratio (Ace/Glxn.i).
There were no significant differences in the concentration of the L- and D- lactate, glucose,
succinate, pyruvate, and urea between any of the cohorts, and none of these metabolites was
predictive of PTD nor delivery within 2 weeks of sampling individually.
Association of CVF cytokines, metabolites and maternal clinical data
The correlations between CVF pro-inflammatory mediators, metabolites (measured by
enzyme-based spectrophotometry) and maternal clinical and demographic details are pre-
sented in Fig 3. After Bonferroni correction to minimise Type 1 error, TNF-r1 positively corre-
lated with IL-1ċ, IL-1Č, IL-6 and negatively with CL. IL-1Č also correlated positively with L/D-
lactate ratio which correlated positively with vaginal pH. Furthermore, D-lactate correlated
positively with glutamate and inversely with vaginal pH. CL and qfFN were also negatively
correlated.
Fig 1. Prevalence of vaginal mixed anaerobic bacterial species in relation to delivery outcome. (A) Preterm vs.
term. The preterm-delivered women had higher prevalence of Fusobacterium sp. (Fuso),Mubiluncus mulieris (Mm),
Mycoplasma hominis (Mh), whereasMubiluncus curtisii (Mc) was more prevalent in term-delivered women though to
a lesser proportion. (B) Delivery within and after 2 weeks. Fusobacterium sp. andM. hominis were more prevalent in
women who delivered within 2 weeks of sampling, whereasM. curtisii andM.mulieris were more prevalent in women
that delivered later than 2 weeks of sampling.
https://doi.org/10.1371/journal.pone.0222455.g001
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Receiver operating characteristic analysis of CVF biomarkers and clinical
details for spontaneous PTB
As shown in S2 Table, RANTES, TNF-r1, IL-6, Ace/Glxconc, BMI, qfFN, which were signifi-
cantly increased and CL, which was significantly decreased in the preterm women were able to
determine risk of sPTD individually, but only RANTES, IL-6, Ace/Glxconc and maternal age
were associated with delivery within 2 weeks of sampling.
Furthermore, certain cytokine-metabolite combinations containing lactate, acetate, Ace/
Glxconc, IL-6, and TNF-r1 were associated with sPTD, while others were associated with deliv-
ery within 2 weeks of sampling (S2 Table).
RANTES, which had the highest individual predictive values for sPTD (AUC = 0.87) and
delivery within 2 weeks of sampling (AUC = 0.91) (Fig 4 and S2 Table) could not be included
in the combination (multibiomarker) models by logistic regression due to reduced number of
samples with detectable RANTES concentrations.
Table 2. Comparison of cervicovaginal fluid cytokine/chemokine concentrations (pg/ml) in relation to delivery
outcomes.
Cytokine/chemokine Term (N = 75) Preterm (N = 19) P-value
TNF-r1 781.4 (283.3–1814.5) (n = 75) 2350.7 (645.7–3795.8) (n = 19) 0.006
IL-1Č 369.5 (69.4–760.8) (n = 61) 785.6 (133.5–1653.4) (n = 9) 0.2
RANTES 40.8 (12.8–67.3) (n = 9) 101.4 (70.7–541.3) (n = 6) 0.02
IL-6 38.3 (6.1–147.2) (n = 47) 207.6 (47.1–524.5) (n = 13) 0.01
IL-8 771.6 (299.3–1385.3) (n = 20) 490.3 (402.5–1827.8) (n = 4) 0.8
IL-1ċ 546.2 (218.7–935.5) (n = 62) 1062.4 (397.6–1816.5) (n = 17) 0.3
Delivery within 2 weeks of sampling
> 2 weeks (N = 84) < 2 weeks (N = 10) P-value
TNF-r1 922.5 (323.2–1936.5) (n = 80) 2083.8 (454.6–3187.0) (n = 10) 0.2
IL-1Č 362.1 (75.2–1018.3) (n = 62) 628.8 (125.9–1883.5) (n = 4) 0.6
RANTES 40.8 (17.9–79.2) (n = 11) 289.1 (89.7–660.2) (n = 4) 0.02
IL-6 47.8 (6.1–147.2) (n = 51) 385.8 (56.8–592.9) (n = 7) 0.03
IL-8 490.3 (273.3–0.0) (n = 22) 490.3 (473.3–0.0) (n = 2) 0.4
IL-1ċ 583.6 (231.8–1138.7) (n = 67) 1062.4 (298.5–1940.9) (n = 9) 0.3
Data presented as median (25th - 75th percentile). Samples without a particular cytokine or cytokine concentration
below the detectable limit of the assay kit (indicated as a value of zero) were omitted in subsequent analyses, hence
the varied n numbers. Significant P-values are marked in bold.
https://doi.org/10.1371/journal.pone.0222455.t002
Table 3. Cervicovaginal fluid metabolites concentrations in relation to delivery outcome.
Metabolites Term Preterm AUC (95% CI) P-value
Acetate 0.02 (0.01–0.03) n = 41 0.04 (0.02–0.08) n = 15 0.79(0.66–0.89) 0.0007
Glutamate 0.07 (0.04–0.10) n = 42 0.07(0.04–0.13) n = 15 0.53(0.40–0.67) 0.7
Acetate/Glutamate ratio 0.27 (0.14–0.50) n = 42 0.83 (0.30–1.89) n = 15 0.74 (0.60–0.85) 0.006
Delivery within 2 weeks
> 2 weeks < 2 weeks AUC (95% CI) P-value
Acetate 0.021 (0.01–0.03) (n = 47) 0.054 (0.02–0.08) (n = 8) 0.73 (0.59–0.84) 0.047
Glutamate 0.068 (0.04–0.10) (n = 49) 0.063 (0.05–0.08) (n = 8) 0.54 (0.41–0.68) 0.7
Acetate/Glutamate ratio 0.282 (0.16–0.58) n = 47 1.153 (0.40–1.77) n = 8 0.74 (0.61–0.85) 0.03
Concentrations of metabolites (g/l) derived by spectrophotometry are presented as median (25th and 75th percentiles). AUC, area under the ROC curve; CI, confidence
interval.
https://doi.org/10.1371/journal.pone.0222455.t003
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Discussion
This study investigated the relationship of CVF inflammatory mediators, microbiota metabo-
lites and risk of imminent sPTD in women presenting with PTL. We observed that women
who delivered preterm or within 2 weeks of sampling demonstrated higher prevalence of
potentially pathogenic vaginal anaerobes in the CVF, and showed significantly higher markers
of vaginal dysbiosis (Ace/Glx ratio), inflammation (RANTES, TNFr-1 and IL-6), shorter CL
Fig 2. Receiver operating characteristic curve analysis of cervicovaginal fluid metabolites in predicting delivery
within 2 weeks of presentation with symptoms of preterm labour. (A) 1H-NMR-derived acetate/glutamate ratio
(Ace/Glx, AUC = 0.86, 0.76–0.93), Acetate (AUC = 0.78, 0.68–0.87) and Glutamate (AUC = 0.68, 0.57–0.78); (B)
Metabolite concentrations measured by enzyme-based spectrophotometry: Ace/Glx (AUC = 0.74, 0.61–0.85), Acetate
(AUC = 0.73, 0.59–0.84) and Glutamate (AUC = 0.54, 0.41–0.68). n.i., normalised integral.
https://doi.org/10.1371/journal.pone.0222455.g002
Fig 3. Correlation of cervicovaginal fluid pro-inflammatory mediators, metabolite concentrations and maternal clinical
and demographic details. Spearman’s correlation coefficients (r, colour) range from -1 (dark blue) to +1 (dark red); and
significant P-values (< 0.05) stated in the coloured boxes. Due to the high number (28) of compared measures, a Bonferroni
corrected value of 0.05/364 = p<0.000137 was applied to minimise Type 1 error. Ace/Glx, acetate/glutamate ratio; CL, cervical
length; BMI, body mass Index; FFN, quantitative fetal fibronectin; Gest., gestational; g.w, gestational week; g.d, gestational day;
labour, latency i.e. interval between presentation and delivery.
https://doi.org/10.1371/journal.pone.0222455.g003
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and increased qfFN. Cytokine-metabolite combinations of total lactate, L/D-lactate ratio, ace-
tate, acetate/glutamate ratio, IL-6, TNF-r1 were also associated with sPTD and delivery within
2 weeks of presentation.
The observed cytokine-metabolite alterations were accompanied by high prevalence of
anaerobes such as Fusobacterium sp.,M. hominis andM.mulieris in women destined to deliver
preterm; while those that delivered within 2 weeks of sampling showed higher prevalence of
Fusobacterium sp. andM. hominis only. This is consistent with reports of elevated CVF IL-6
and positive cultures of Ureaplasma urealyticum andM. hominis in the chorioamniotic mem-
branes in women with symptoms of PTL [25]. Our observations are also consistent with
reports that vaginal communities dominated by anaerobes are potentially associated with
greater pro-inflammatory cytokine responses than Lactobacilli-dominated niches [26, 27].
Increased vaginal concentrations of acetate and glutamate have contrasting implications for
reproductive health. Acetate in the vaginal milieu is produced majorly by anaerobes, especially
when Lactobacilli are deficient [28–30], and high amounts are associated with infection and
PTD [9, 10, 18, 30]. Contrastingly, high vaginal glutamate level, similar to D-lactate, is associ-
ated with healthy microbiota dominated by Lactobacilli [11, 31] and decreased prevalence of
anaerobes that are known to metabolise amino acids to their catabolic by-products [11] includ-
ing acetate [18, 30]. For instance, Fusobacterium sp. which was more prevalent in the women
who delivered preterm and within 2 weeks of sampling, ferments glutamate to acetate via the
hydroxyglutarate pathway [32, 33]. Such metabolic processes explain our observation that the
Ace/Glx ratio was associated with sPTD and delivery within 2 weeks of sampling. It is note-
worthy that glutamate alone was not associated with delivery within 2 weeks, while acetate
alone was to a lesser extent associated with imminent sPTD [9, 10]. Therefore, the Ace/Glx
ratio was more strongly associated with delivery within 14 days of sampling than either acetate
Fig 4. Receiver operating characteristic curve analysis of cervicovaginal fluid RANTES (A-B) and IL-6 (C-D) in
predicting preterm delivery and delivery within 2 weeks of presentation with symptoms of preterm labour. AUC,
area under the ROC curve.
https://doi.org/10.1371/journal.pone.0222455.g004
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or glutamate individually. Furthermore, decreased glutamate, D-lactate, and increased L/D-
lactate ratio were associated with high vaginal pH.
Despite our limited sample size, an association of CVF RANTES, IL-6 and TNF-r1 with
sPTD within 14 days was also demonstrated. Additionally, the combination of metabolite indi-
ces (acetate, glutamate, L- and D-lactate) and cytokine concentrations were similarly associ-
ated with imminent sPTD, observations which are reflective of vaginal host-microbial
interactions [34], being downstream products of gene expression and protein synthesis [35–
37]. Our study gives additional insight into the role played by the vaginal ecosystem and host
immune responses in the propagation of sPTD [38], and whether specific cytokine-metabolite
combinations can be used to screen for women at high risk of imminent sPTD.
Elevated blood, serum and CVF RANTES at mid to late gestation has been associated with
sPTD in both symptomatic [3, 37] and asymptomatic women [15, 39], as well as murine mod-
els [40]. We recently reported decreased CVF RANTES from mid to late second trimester in
asymptomatic women who delivered at term compared to their preterm counterparts in
whom levels remained unchanged [15]. RANTES is a potent chemoattractant and inducer of
inflammatory mediators involved in parturition and is produced by immune, endothelial and
gestational tissues [37, 41, 42].
Apart from RANTES, TNF-r1 (that binds TNF-ċ) and IL-6 were also increased in women
who delivered preterm. IL-6 was additionally associated with delivery within 2 weeks. These
pro-inflammatory mediators are implicated in the NF-ĔB-p38MAPK-orchestrated inflamma-
tory cascade implicated in sPTL leading to myometrial contraction, cervical remodelling, and
degradation/rupture of fetal membranes [31, 43–45]. TNF-ċ is detectable early in the amniotic
fluid following bacterial colonisation and stimulates the production of IL-6, IL-8, matrix
metalloproteinases and PGE2 during infection-associated PTL [42]. IL-6 activates the acute
phase response [46] and, along with TNF-ċ, which were correlated in our study, correlates
with qfFN [47] and is associated with PTD [48–50].
An altered vaginal microbiota with reduced Lactobacillus sp. dominance may increase vagi-
nal pH creating a permissive environment for the proliferation of pathogenic anaerobes [51].
There is also a direct link between vaginal dysbiosis, short cervix [45, 52], and disrupted fetal
membranes with consequent leakage of fFN into the cervicovaginal space [7, 45, 53]. Therefore,
a high CVF Ace/Glx ratio could be suggestive of a dysbiosis with associated reduced D-lactate,
glutamate and vaginal acidity, increased expression of pro-inflammatory mediators, shortened
cervix and elevated qfFN as shown in this study and other reports [3, 15, 25, 30, 31, 45, 50].
Hitherto, no multivariable model of inflammatory mediators and cervical length associated
with imminent sPTD in symptomatic [3, 54] and asymptomatic women [15, 55] has achieved
clinical utility. Interestingly, we observed amongst others that combination of CVF: 1) acetate,
lactate, IL-6 and TNF-r1; and 2) Ace/Glx ratio, L/D-lactate ratio and IL-6 were associated with
sPTD and delivery within 14 days of sampling, respectively.
Two recent extensive systematic reviews of the accuracy of qfFN for the prediction of PTD
within 7 to 10 days of testing in symptomatic women reported pooled sensitivities of 75% and
77%; and pooled specificities of 79% and 83% respectively [56, 57]. Both our single and multi-
variable cytokine-metabolite models on a similar cohort showed greater sensitivities and speci-
ficities for determining sPTD within 2 weeks of sampling respectively. However, there is the
need to test these findings in larger and more diverse study populations.
Conclusion
Symptomatic women destined to deliver preterm within 2 weeks express significantly higher
pro-inflammatory mediators at mid to late gestation. In this cohort, RANTES, IL-6, and
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acetate/glutamate ratio; were more associated with imminent preterm delivery compared to
other biomarkers. The combination of CVF metabolites and pro-inflammatory mediators
appears able to distinguish symptomatic women at risk of imminent preterm birth. This
approach may improve the triaging of such women, allowing patients to be discharged to out-
patient care whilst sign-posting neonatal high-dependency care to those at highest risk. A
larger study is required to confirm these observations and determine the cost utility of this
approach in clinical care.
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